DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Paclitaxel (Paclitaxel) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (182)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 182   Next >>

Possible Paclitaxel side effects in female

Reported by a physician from Mexico on 2012-08-22

Patient: female, weighing 48.0 kg (105.6 pounds)

Reactions: Hypovolaemic Shock, Cerebrovascular Accident, Cerebral Ischaemia, Hemiplegia, Thrombocytopenia, Acute Respiratory Failure, Hypovolaemia, Epistaxis

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-05-19
    End date: 2010-05-28

Comparator Trastuzumab
    Dosage: 120 mg, daily
    Indication: Breast Cancer Metastatic
    Start date: 2010-05-19
    End date: 2010-05-26

Paclitaxel
    Dosage: 192 mg, daily
    Indication: Breast Cancer Metastatic
    Start date: 2010-05-19
    End date: 2010-05-26



Possible Paclitaxel side effects in female

Reported by a physician from South Africa on 2012-08-22

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Renal Impairment, Neoplasm Malignant, Skin Lesion, Sepsis, Dehydration, Cardiac Arrest, Pneumonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Comparator Trastuzumab
    Dosage: 2 mg/kg, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Paclitaxel
    Dosage: 80 mg/m2, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Other drugs received by patient: Zamanon; Marinol; Metformin; Maxolon



Possible Paclitaxel side effects in 54 year old female

Reported by a physician from United States on 2012-08-21

Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Pancytopenia, Platelet Count Decreased, Device Related Infection, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 mg/kg, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Carboplatin
    Dosage: 6 df, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Cyclophosphamide
    Dosage: 600 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Paclitaxel
    Dosage: 80 mg/m2, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Pegfilgrastim
    Dosage: 480 mug, unk
    Indication: Chemotherapy
    Start date: 2011-12-22

Other drugs received by patient: Tylenol (Caplet); Emend; Levaquin; Decadron; Zofran / 00955302 /; Aloxi; Compazine



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-21

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Cytomegaloviral

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Dosage: last dose prior to sae: 18/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-06-14

Paclitaxel
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-08-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Haemorrhage Intracranial, Sepsis, Hypotension, Pneumonia Streptococcal, Failure To Thrive, Acute Respiratory Failure, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Other drugs received by patient: Naproxen; Dexamethasone; Zometa; Dextrose; Ativan; Diphenhydramine HCL; Neulasta; Lortab; Robaxin; Fosphenytoin Sodium; Ciprofloxacin; Magnesium Sulfate; Lasix; Ferrous Sulfate TAB; Remeron; Artificial Tears; Amlodipine Besylate; Benadryl; Hydrocodone; Celexa; Acetaminophen; Lorazepam; Phenergan HCL; Potassium Chloride; Hydrocodone Bitartrate + Acetaminophen; Protonix; Aloxi; Mineral OIL; Insulin Aspart; Morphine Sulfate; Zofran; Cocaine; Udderly Smooth Cream



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Sepsis, Pneumonia Streptococcal, Hypotension, Haemorrhage Intracranial, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Other drugs received by patient: Dexamethasone; Protonix; Zosyn; Insulin Aspart; Udderly Smooth Cream; Benadryl; Naproxen; Celexa; Aloxi; Diphenhydramine HCL; Zometa; Phenergan HCL; Acetaminophen; Fosphenytoin Sodium; Lortab; Lorazepam; Cocaine; Potassium Chloride; Ceftriaxone; Mineral OIL; Lasix; Levophed; Ferrous Sulfate TAB; Ciprofloxacin; Dextrose; Vancomycin HCL; Ativan; Neulasta; Robaxin; Artificial Tears; Hydrocodone; Remeron; Zofran; Hydrocodone Bitartrate + Acetaminophen; Magnesium Sulfate; Phenytoin Sodium



Possible Paclitaxel side effects in male

Reported by a physician from Japan on 2012-08-15

Patient: male, weighing 51.0 kg (112.2 pounds)

Reactions: Haemoptysis, Interstitial Lung Disease, Platelet Count Decreased, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Start date: 2010-11-16
    End date: 2010-11-16

Avastin
    Start date: 2010-12-16
    End date: 2010-12-16

Avastin
    Start date: 2010-10-14
    End date: 2010-10-14

Avastin
    Indication: Lung Adenocarcinoma Recurrent
    Start date: 2010-08-17
    End date: 2010-08-17

Avastin
    Start date: 2010-09-14
    End date: 2010-09-14

Carboplatin
    Start date: 2010-09-14
    End date: 2010-09-14

Carboplatin
    Start date: 2010-12-16
    End date: 2010-12-16

Carboplatin
    Start date: 2010-11-16
    End date: 2010-11-16

Carboplatin
    Indication: Lung Adenocarcinoma Recurrent
    Start date: 2010-08-17
    End date: 2010-08-17

Carboplatin
    Start date: 2010-10-14
    End date: 2010-10-14

Paclitaxel
    Start date: 2010-09-14
    End date: 2010-09-14

Paclitaxel
    Indication: Lung Adenocarcinoma Recurrent
    Start date: 2010-08-17
    End date: 2010-08-17

Paclitaxel
    Start date: 2010-10-14
    End date: 2010-10-14

Paclitaxel
    Start date: 2010-12-16
    End date: 2010-12-16

Paclitaxel
    Start date: 2010-11-16
    End date: 2010-11-16



Possible Paclitaxel side effects in 74 year old female

Reported by a physician from United States on 2012-08-15

Patient: 74 year old female, weighing 72.0 kg (158.4 pounds)

Reactions: Myelodysplastic Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 600 mg/m2 iv over 30 min, on day 1 q21 dayx 4, date of last drug taken prior to onset of ae:18/jun/2
    Indication: Breast Cancer
    Start date: 2002-04-08

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2 intravenous push on day 1 every21 days x 4,date of last drug taken prior to onset of ae:18/
    Indication: Breast Cancer
    Start date: 2002-04-08

Herceptin
    Dosage: 4mg/kg over 90min (loading dose) on day1 of wk13 only,2mg/kg over 30 min (maintenance dose) qwk for
    Indication: Breast Cancer
    Start date: 2002-04-08

Paclitaxel
    Dosage: 175 mg/m2 over 3 hr q 21d starting day 1 of wk 13x 4, date of last drug taken prior to onset of ae:1
    Indication: Breast Cancer
    Start date: 2002-04-08



Possible Paclitaxel side effects in male

Reported by a physician from Japan on 2012-08-13

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Intestinal Ischaemia, Disseminated Intravascular Coagulation, Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Avastin
    Indication: Lung Adenocarcinoma Metastatic
    Start date: 2012-06-19
    End date: 2012-07-18

Carboplatin
    Indication: Lung Adenocarcinoma Metastatic
    Start date: 2012-06-19
    End date: 2012-07-18

Paclitaxel
    Indication: Lung Adenocarcinoma Metastatic
    Start date: 2012-06-19
    End date: 2012-07-18

Other drugs received by patient: Decadron Phosphate; Aloxi



Possible Paclitaxel side effects in 54 year old male

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: 54 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Hypotension, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: most recent dose on 1aug12
    Start date: 2012-07-30

Paclitaxel
    Dosage: most recent dose on 1aug12
    Start date: 2012-07-30



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-10

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Cytomegaloviral

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Dosage: last dose prior to sae: 18/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09



Possible Paclitaxel side effects in 69 year old male

Reported by a pharmacist from United States on 2012-08-09

Patient: 69 year old male, weighing 91.0 kg (200.2 pounds)

Reactions: Hypotension, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Paclitaxel



Possible Paclitaxel side effects in female

Reported by a physician from China on 2012-08-06

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Death, Cardiac Failure

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: most recent dose prior to the event: 21/mar/2012, 840 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-05

Carboplatin
    Dosage: most recent dose prior to event: 21/mar/2012, 739 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-05

Paclitaxel
    Dosage: most recent dose prior to event: 21/mar/2012, 265 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-05



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-06

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Viral, Interstitial Lung Disease, Respiratory Failure, Multi-Organ Disorder, Pulmonary Mycosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: 750 milligram daily;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Other drugs received by patient: Acetaminophen; Thyranojod



Possible Paclitaxel side effects in 38 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-06

Patient: 38 year old female

Reactions: Dyspnoea, Hypersensitivity, Arthralgia, Hypotension, Cyanosis Central

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Paclitaxel



Possible Paclitaxel side effects in 75 year old female

Reported by a physician from United States on 2012-08-02

Patient: 75 year old female, weighing 49.7 kg (109.4 pounds)

Reactions: Activated Partial Thromboplastin Time Prolonged, Fatigue, Hypocalcaemia, White Blood Cell Count Decreased, Vomiting, Nausea, Hypotension, Renal Failure Chronic, Hypophosphataemia, Syncope, Respiratory Failure, Embolism, Diarrhoea, Aspartate Aminotransferase Increased, Hypermagnesaemia, Hypoalbuminaemia, Neutrophil Count Decreased, Enterocolitis Infectious

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: over 30-90 minutes on day 1 of cycles 2+. drug withdrawn.
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31
    End date: 2012-02-21

Carboplatin
    Dosage: auc=6 iv on day 1 (cycle 1-6)
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31

Paclitaxel
    Dosage: over 3 hours on day 1 (cycles, 1-6).
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31



Possible Paclitaxel side effects in female

Reported by a physician from Mexico on 2012-07-30

Patient: female, weighing 48.0 kg (105.6 pounds)

Reactions: Hypovolaemic Shock, Cerebrovascular Accident, Cerebral Ischaemia, Hemiplegia, Acute Respiratory Failure, Thrombocytopenia, Epistaxis, Hypovolaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-05-19
    End date: 2010-05-28

Comparator Trastuzumab
    Dosage: 120 mg, daily
    Indication: Breast Cancer Metastatic
    Start date: 2010-05-19
    End date: 2010-05-26

Paclitaxel
    Dosage: 192 mg, daily
    Indication: Breast Cancer Metastatic
    Start date: 2010-05-19
    End date: 2010-05-26



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-27

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Anaemia, Tachycardia, Pyrexia, Multi-Organ Failure, Urosepsis, Acute Respiratory Distress Syndrome, Oedema, Hypoxia, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Metoprolol Tartrate; Xanax; Vicodin; Benadryl; Protonix



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-26

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Viral, Interstitial Lung Disease, Respiratory Failure, Pyrexia, Multi-Organ Disorder, Pulmonary Mycosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: 750 milligram;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Other drugs received by patient: Thyranojod; Acetaminophen



Possible Paclitaxel side effects in female

Reported by a physician from China on 2012-07-24

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Death, Cardiac Failure

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: most recent dose prior to the event: 21/mar/2012
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-05

Carboplatin
    Dosage: most recent dose prior to event: 21/mar/2012, 739 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-05

Paclitaxel
    Dosage: most recent dose prior to event: 21/mar/2012, 265 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-05



Possible Paclitaxel side effects in 64 year old female

Reported by a physician from United States on 2012-07-23

Patient: 64 year old female, weighing 102.0 kg (224.4 pounds)

Reactions: Abdominal Pain, Hyponatraemia, Disease Progression, Soft Tissue Infection, Death, Fatigue, Colonic Fistula, Hypermagnesaemia, Hypoalbuminaemia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Carboplatin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Paclitaxel
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03



Possible Paclitaxel side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-19

Patient: 66 year old female

Reactions: Anaphylactic Shock, Loss of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Paclitaxel
    Dosage: 150 mg milligram(s), intravenous
    Indication: Ovarian Cancer
    Start date: 2012-06-18
    End date: 2012-06-18

Paclitaxel
    Dosage: 100 mg milligram(s), intravenous
    Indication: Ovarian Cancer
    Start date: 2012-06-18
    End date: 2012-06-18

Other drugs received by patient: Aloxi; Dexamethasone Sodium Phosphate; Trimeton; Omeprazole



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-19

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Pneumonia Streptococcal, Sepsis, Haemorrhage Intracranial, Hypotension, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic



Possible Paclitaxel side effects in female

Reported by a physician from Japan on 2012-07-18

Patient: female

Reactions: Urinary Tract Infection, Oedema Peripheral, Genital Herpes Zoster, Pleural Effusion, Duodenal Ulcer Haemorrhage, Gastric Ulcer, Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-03
    End date: 2012-04-20

Loxonin
    Dosage: when needed
    Administration route: Oral
    Indication: Pain
    Start date: 2012-01-27

Paclitaxel
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-20
    End date: 2012-04-20

Other drugs received by patient: Ferrous Sulfate TAB; Miya BM; Rabeprazole Sodium; Vitaneurin; Loperamide Hydrochloride; Mucosta



Possible Paclitaxel side effects in female

Reported by a physician from China on 2012-07-18

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Death, Cardiac Failure

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: most recent dose prior to the event: 21/mar/2012
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-05

Carboplatin
    Dosage: most recent dose prior to event: 21/mar/2012, 739 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-05

Paclitaxel
    Dosage: most recent dose prior to event: 21/mar/2012, 265 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-05



Possible Paclitaxel side effects in 64 year old female

Reported by a physician from United States on 2012-07-18

Patient: 64 year old female, weighing 102.0 kg (224.4 pounds)

Reactions: Abdominal Pain, Hyponatraemia, Disease Progression, Death, Soft Tissue Infection, Fatigue, Colonic Fistula, Hypermagnesaemia, Hypoalbuminaemia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Carboplatin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Paclitaxel
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Dyspnoea, Pneumonia, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Hypoxia, Urosepsis, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Vicodin; Xanax; Metoprolol Tartrate; Benadryl; Protonix



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Hypotension, Sepsis, Haemorrhage Intracranial, Pneumonia Streptococcal, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic



Possible Paclitaxel side effects in 58 year old female

Reported by a physician from Philippines on 2012-07-17

Patient: 58 year old female, weighing 95.3 kg (209.6 pounds)

Reactions: Grand MAL Convulsion, Eye Movement Disorder

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Paclitaxel
    Dosage: 330 mg, intravenous
    Indication: Chemotherapy
    Start date: 2012-06-30
    End date: 2012-06-30

Paclitaxel

Other drugs received by patient: Dexamethasone Sodium Phosphate; Ranitidine Hydrochloride; Diphenhydramine HCL



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Urosepsis, Hypoxia, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Xanax; Metoprolol Tartrate; Vicodin; Benadryl; Protonix; Duoneb; Lovenox



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017